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A B S T R A C T
Purpose: We employed the results of imagingmodalities from pediatric patients who received successful
epilepsy surgery to determine the accuracy of each imaging tool in identifying epileptic zones in
youngsters.
Methods: All Engel class I pediatric patients who received epilepsy surgery between October 2003 and
April 2008were selected. Their pathology, EEG, MRI, PET, and subtraction ictal SPECT coregistered toMRI
(SISCOM) results were compared for accuracy in locating the epileptic foci, deﬁned as ‘‘area that resulted
in seizure ablation after resection’’.
Results: Forty-two patients were enrolled (23 temporal lobectomy, 19 extratemporal resections). MRI
showed concordance in 84.2% of extratemporal cases, all of which had precise localization of lesions. In
temporal cases, lateralization was 91.3% and localization was 82.6%. PET showed a concordance rate of
95.5% and localization was 72.7% for temporal lesions. For extratemporal lesions, concordance was only
68.4%. SISCOM showed concordance in 100% of temporal and 92.3% of extratemporal cases, with
localization in 66.7% of temporal and 84.6% of extratemporal cases. Most temporal lobe cases had
hippocampal sclerosis, and cortical dysplasia was observed in extratemporal cases.
Discussion: MRI was invariably reliable in all cases. PET results were as reliable in lateralizing the
temporal epileptic area, while its efﬁcacy was lower for extratemporal cases. SISCOM effectively
localized lesions in extratemporal cases, but its efﬁcacy was lower in temporal lesions. In cases of
conﬂicting pre-surgical results, MRI, with supplementary data from PET, helped to establish correct
decisions in temporal epilepsies, while utilization of SISCOM and MRI data is advised for extratemporal
cases.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Over the past several years, development of newer and effective
antiepileptic medications have instigated profound advancement
in the medical treatment of epilepsy, resulting in better
compliance and effectiveness in the care of pediatric patients
suffering from repeated seizures. There is still, however, a subset of
patients who prove to be refractory to appropriate medical
treatment, which accounts for approximately 30–40% of the totalAbbreviations: SISCOM, Subtraction Ictal SPECT Coregistered to MRI.
* Corresponding author. Tel.: +82 2 2228 2050; fax: +82 2 393 9118.
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doi:10.1016/j.seizure.2009.04.012cases.1 Epilepsy surgeries are one of the most effective treatment
modalities in patients suffering from intractable epilepsy2 and
yields fairly high rate of seizure-free outcomes that range from
47.2% to as high as 64% if implemented in proper patient groups in
a timely and accurate manner.3,4 Among this subset of intractable
patients, those who are eligible for focal surgical resections are
fortunate in that they can expect to have better operative
outcomes than their counterparts in whom only palliative surgical
treatments are possible.5 Hence, it is of utmost importance that
physicians properly recognize patients with focal onset seizures,
and coupled with the fact that radical surgical treatments in
children are better tolerated than adults due to the plasticity of
immature pediatric brain,6 proper delineation of focal epileptic
zones and early implementation of surgery in intractable pediatricvier Ltd. All rights reserved.
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expectation of satisfactory outcome.
For this reason, rigorous investigation into detecting epileptic
foci is paramount. Electroencephalogram (EEG) remains, even after
80 years since its ﬁrst conception by Hans Berger, the most
powerful tool in our arsenal for delineating the epileptic foci, and is
the primary tool in the selection and evaluation of presurgical
candidates at most institutions. Additional data from neuroima-
ging modalities such as magnetic resonance imaging (MRI) also
plays an indispensable role, and the validity of 18F-ﬂuorodeox-
yglucose (FDG) positron emission tomography (PET), ictal perfu-
sion 99mTc-ethyl cysteinate dimer (ECD) single photon emission
computed tomography (SPECT), and the more recently developed
subtraction ictal SPECT coregistered toMRI (SISCOM) have all been
proven in adult epileptic patients.7–9 In pediatric patients,
however, data on the effectiveness of these imaging modalities
are still lacking, and even though most institutions employ these
methods for their presurgical pediatric candidates, most research-
ers still state the need for further studies to verify the accuracy and
effectiveness of these modalities in localizing the epileptogenic
foci in immature brains.
We have, therefore, accumulated epileptic surgical results from
pediatric patients at our institution for the last four and a half
years, and evaluated the effectiveness of various imaging
modalities, encompassing MRI, PET, and SISCOM, for detecting
the seizure foci as veriﬁed by surgical outcomes of temporal lobe
lesions, which ismost frequently the site of surgical treatment, and
extratemporal lesions.
2. Materials and methods
2.1. Patients
All pediatric patients who were admitted to Severance
Children’s Hospital from October 2003 to April 2008 and received
epilepsy surgery were evaluated. Patients who received focal
lobectomies or cortisectomies after delineation of epileptic lesions
were selected (Table 1), and cases where precise localization of
epileptic foci were possible through analysis of post-operative
results, namely, patients with class I of Engel’s classiﬁcation of
post-operative outcome,10 were selected for enrollment in this
study. Select patients were divided into temporal and extra-
temporal lesion groups in accordance to their epileptic foci, and the
results of their presurgical EEG, MRI, FDG-PET, and SISCOM
obtained from ictal and interictal ECD-SPECT were retrospectively
analyzed (Table 2). Post-operative pathological ﬁndings were also
examined.
2.2. EEG
All candidates were examined by video-EEG monitoring in
electroencephalographic monitoring unit (EMU) to search for the
epileptogenic foci. The international 10–20 system was used forTable 1
Total post-operative outcomes of pediatric patients
after epilepsy surgery.
Temporal area
Engel class I 19 (55.9%)
Engel class II 12 (35.3%)
Engel class III 3 (8.8%)
Engel class IV 0
Extratemporal area
Engel class I 23 (76.7%)
Engel class II 1 (3.3%)
Engel class III 1 (3.3%)
Engel class IV 5 (16.7%)tracing. In patientswhom surgical treatmentwas deemed possible,
subsequent evaluation utilizing surgically placed subdural elec-
trodes were carried out to further delineate the lesion. Surgical
feasibilitywas discussed at a boardmeeting attended by specialists
in child neurology, diagnostic radiology, and pediatric neurosur-
gery. Epileptogenic lesions were delineated primarily through
interpretation of EEG data, and other imaging modalities were
used to reinforce the results by labeling them as either concordant
or discordant. In cases of conﬂicting results between evaluative
modalities, extracranial EEG results were primarily used for
determining the extent of subdural electrode placement, and
direct cerebral monitoring results obtained by subdural electrodes
were used to determine surgical resective margins.
2.3. MRI
Standard MRI was performed with conventional spin–echo T1-
weighted sagittal, T2-weighted axial, ﬂair axial, oblique coronal,
and ﬂair oblique coronal sequences, as well as with ultrafast
gradient echo (TFE) T1-weighted 3D coronal sequences. A Philips
MRI Achieva 3.0T Release 2.5.3.3 (USA) was used to acquire
seizure-specialized sequences termed seizure phase 1 images, in
accordancewith the protocol described in Table 3. In this study, 3D
T1-weighted TFE magnetization-prepared rapid acquisition with
gradient-echo sequence and both oblique coronal sequences with
3 mm thick sections were obtained from the oblique coronal plane
of the temporal lobes perpendicular to the long axis of the
hippocampus.
2.4. FDG-PET
PET images were acquired using a GE ADAVANCE PET Scanner
(GE, Milwaukee, WI, USA) in 3D mode. The transaxial resolution of
the system was 5.2 mm FWHM (full-width-half maximum) at the
center of FOV (ﬁeld of view). Approximately 5 mCi of 18F-FDG was
injected intravenously after 6 h of fasting, and patients were either
sedated if uncooperative, or if cooperative, asked to lie still with
their eyes closed in a quiet, dimly lit room during injection and
following 40 min. The emission scan started at 40 min after
injection and lasted 15 min, and an 8 min transmission scan was
subsequently acquired for the purpose of attention correction. EEG
was performed during FDG uptake using portable EEG with an
international 10–20 system, and its tracing was later examined for
presence of possible ictal discharges during acquisition of the
images.
2.5. SISCOM
For acquisition of SISCOM images, patients underwent ictal and
interictal single photon emission computed tomography (SPECT)
studies at an interval of less than 1 week. As a radiotracer,
approximately 740-925 MBq of technetium-99m ethyl cysteinate
dimer (ECD) was administered intravenously. Continuous video
EEGmonitoringwas performed at the EMUand the radiotracerwas
intravenously injected during the ictal period for acquisition of
ictal SPECT. Seizure onset was deﬁned as the time of earliest
indication of auras or the beginning of the rhythmic ictal
discharges on EEG. Seizure termination was deﬁned as the time
when ictal movement ceased or the time of termination of the ictal
discharge. Brain images were obtained using a brain-dedicated
annular crystal gamma camera (Digital Scintigraphic Incorporated,
Waltham, MA) equipped with low-energy, high-resolution paral-
lel-hole collimators. The full-width at half maximum (FWHM) of a
high-resolution collimator is typically 7.5 mm at the center of
rotation (COR) and 5.8 mm at the peripheral regions 9 cm from the
COR. SPECT studieswere acquired for 20 min in a 128  128matrix
Table 2
Summary of patient speciﬁcs, duration of surgery, medical treatment, follow up, post-operative pathological ﬁndings, and concordance and localization abilities of analytical
tools examined.
Patient Sex Age of Sz
onset (year)
Duration of Sz
until op (year)
Op age
(year)
Duration of
F/U (year)
Site of Sz EEG MRI PET SISCOM Pathology
(cortex)
Pathology
(hippocampus)
1 M 7.00 12.33 19.33 2.92 LAT + AH 1 1 2 4 Nl HS
2 F 10.00 5.83 15.83 2.58 RTL + AH 1 3 1 4 Nl HS
3 M 9.67 1.33 11 2.25 LTL + AH 1 1 2 2 DNET Nl
4 M 7.00 13.08 20.08 2.00 LTL + AH 1 2 1 1 Nl HS
5 M 6.00 3.25 9.25 1.67 LTL 1 1 1 4 MD
6 M 5.67 5.41 11.08 1.33 LTL + AH 1 1 1 1 GG Nl
7 F 4.00 14.08 18.08 1.08 RAT + AH 1 1 1 4 Nl HS
8 M 8.00 7.42 15.42 0.67 RTL + AH 1 1 1 1 Nl HS
9 M 7.00 15.50 22.50 0.25 LAT + AH 1 1 1 4 Nl HS
10 M 8.50 3.58 12.08 0.17 LAT + AH 1 1 1 2 CD Nl
11 M 6.00 16.00 22.00 1.25 LAT + AH 2 1 1 4 Nl HS
12 F 10.00 7.75 17.75 0.33 LAT + AH 1 3 4 4 DA DA
13 M 15.00 12.92 27.92 0.83 RAT + AH 2 1 1 1 Nl HS
14 F 12.00 6.42 18.42 0.83 RAT + AH 2 1 1 1 Nl HS
15 M 8.00 17.50 25.50 1.17 RAT + AH 2 2 1 2 Nl HS
16 M 15.00 18.17 33.17 1.17 LAT + AH 1 1 1 4 Nl HS
17 M 0.25 28.33 28.58 1.25 LAT + AH 1 1 2 2 Nl HS
18 M 8.00 22.83 30.83 1.42 LAT + AH 2 1 3 4 MD Nl
19 M 8.00 14.67 22.67 1.50 LAT + AH 1 1 2 1 MD HS
20 M 13.00 20.75 33.75 1.67 RAT + AH 1 1 1 4 Nl HS
21 M 9.00 20.50 29.50 1.83 RAT + AH 1 1 1 4 Nl HS
22 M 3.00 13.25 16.25 0.17 LAT + AH 1 1 1 1 Nl HS
23 M 12.00 37.67 49.67 2.08 RAT + AH 1 1 1 1 Nl HS
24 F 0.08 9.12 9.20 4.63 Rt Occ 1 1 1 1 CD
25 F 5.25 0.50 5.75 4.58 Rt FL 1 1 1 1 CD
26 M 5.08 10.34 15.42 4.08 Rt FL 1 1 1 1 MD
27 M 9.83 2.09 11.92 3.66 Rt Occ 1 1 1 4 GG
28 M 3.08 4.84 7.92 3.33 Lt FL 1 1 1 4 CD
29 M 0.25 4.58 4.83 3.25 Lt FL 1 3 1 1 Nl
30 M 0.50 2.08 2.58 3.00 Rt FL 1 3 3 2 DSG
31 M 1.67 1.58 3.25 2.83 Rt FL 1 3 3 1 MD
32 M 0.17 11.66 11.83 2.42 Lt FL 1 1 3 4 MD
33 F 0.17 1.50 1.67 1.83 Lt FL 1 1 3 1 CD
34 F 8.08 12.84 20.92 1.83 Rt FL 1 1 1 1 CD
35 M 0.50 7.92 8.42 1.75 Lt FL 1 1 3 3 MD
36 M 11.42 5.83 17.25 1.58 Rt FL 1 1 2 4 MD
37 M 10.67 3.08 13.75 1.25 Lt PL 1 1 1 1 GG
38 F 0.42 0.91 1.33 0.92 Lt FL 1 1 3 4 MD
39 F 3.17 2.25 5.42 0.58 Rt Occ 1 1 1 1 GG
40 F 1.50 6.50 8.00 0.42 Rt FL 1 1 1 1 CD
41 M 12.25 10.00 22.25 0.25 Lt PL 1 1 1 1 CD
42 M 4.92 2.16 7.08 0.25 Lt FL 1 1 1 4 DNET
M:male, F: female, 1: localization, 2: lateralization, 3: discordant, 4: not performed, LAT: left anterior temporal lobectomy, RAT: right anterior temporal lobectomy, RTL: right
temporal lobectomy, LTL: left temporal lobectomy, AH: anterior hippocampectomy, FL: frontal lobectomy, Occ: occipital lobectomy, PL: parietal lobectomy, Nl: normal,
DNET: dysembryoplastic Neuroepithelial Tumor, MD: microdysgenesis, GG: ganglioglioma, CD: cortical dysplasia, DA: diffuse astrocytoma, DSG: diffuse subpial gliosis, HS:
hippocampal sclerosis.
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the ﬁltered back-projectionmethod using a Butterworth ﬁlter (cut-
off frequency of 1.1 cycles/cm, order no. 10). Attenuation
correction was performed by Chang’s method after correcting
for scatter by the dual-energy window method, and coronal and
sagittal images were generated.
After acquisition of ictal and interictal SPECT images, 32
transaxial slices of both ictal and interictal scans were recon-
structed and each paired image was generated with the sameTable 3
Speciﬁc parameters of MRI seizure phase 1 protocol.
FOV (mm) Matrix Spatial re
T1W SAG 230  200 256  186 0.9  1.12
T2W AX 230  184 400  255 0.57  0.7
T2W ﬂair AX 230  183 352  189 0.65  0.9
T2W oblique COR 230  183 512  324 0.45  0.5
T2W ﬂair oblique COR 230  182 352  189 0.65  0.9
T1W 3D COR 220  220 224  224 0.98  0.9
Philips MRI Achieva 3.0T Release 2.5.3.3 version. Both Oblique COR sequences were obtai
of the hippocampus. 3D T1W TFE is magnetization-prepared rapid acquisition with grorientation and level for the construction of subtraction images.
Paired ictal and interictal transaxial images were normalized to
the total counts, and interictal images were subtracted from ictal
images on a CeraSPET workstation (Digital Scintigraphic Incor-
porated, Waltham, MA). Subtraction images were generated
without applying a threshold and were qualitatively evaluated.
Seizure localization was determined when pixels on ictal scans
showed higher values than on interictal scans in corresponding
regions.solution (mm) Thickness/gap (mm) Etc
5/1 Conventional spin–echo
2 5/2
7 5/2
7 3/0.3
7 3/0.3
8 1.5 3D T1W TFE
ned in the oblique coronal plane of the temporal lobes perpendicular to the long axis
adient-echo sequence.
Fig. 1. Localization, lateralization, and discordance ratio of the epileptic foci for EEG.
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Epileptic focus was deﬁned as the area that resulted in seizure
ablation upon resection.
2.7. Concordance and discordance
All evaluative tools were categorized into concordant and
discordant groups. Concordance was deﬁned as a tool’s ability to
localize epileptogenic lesionswith precision, or failing that, at least
lateralize lesions to a certain hemisphere. Failure of a diagnostic
tool to visualize the epileptic foci, or presentation of excessively
diffuse epileptic lesions to the extent that it makes it impossible to
ﬁnd the problematic area with precision were deﬁned as
‘‘discordant’’.
2.8. Statistics
Each test was compared for the deduction of their lateralizing
and localizing abilities in both extratemporal and temporal lesions,
through calculation of their respective sensitivities. Fisher’s exact
test was used to compare concordance and localization power
between the temporal lobe and extratemporal lobe by EEG, MRI,
FDG-PET, or SISCOM in combination. The conjunctive lateralizing
and localizing abilities of multiple modalities were calculated
through Chi-square tests, and the statistical differences of their
ability to ﬁnd the epileptic foci in extratemporal and temporal
areas were analyzed. SAS version 9.1 (SAS Inc., North Carolina) was
utilized for this study, and p values <0.05 were considered
statistically signiﬁcant.
3. Results
From a total of 64 surgical cases, 42 patients were selected for
enrollment. Nineteen patients received temporal lobectomies and
23 patients received extratemporal focal cortisectomies or
lobectomies. All patients satisﬁed Engel’s class I post-operative
outcomes at the time of this study, as observed during a mean
follow-up period of 2.15 years (0.59–5.05). Mean age of ﬁrst
seizure onset was 6.45 years (0.08–15.00), and the mean age ofTable 4
Summary of patient data.
Total patients enrolled 42
Male/female 31/11 (< 73.8% , 26.2%)
n temporal lesion 23 (54.8%)
n extratemporal lesion 19 (45.2%)
Mean age at onset 6.45 years (0.08–15.00)
Mean age at surgery 16.42 years (1.34–49.67)
Duration from seizure onset to surgery 9.96 years (0.5–37.67)
Duration of follow up since surgery 2.15 years (0.59–5.05)epilepsy surgery was 16.42 years (1.33–49.67). Patients were
treated for an average of 9.96 years (0.50–37.67) before receiving
surgery (Table 2). Dual pathologies were absent in our cohort
(Table 4).
3.1. EEG
Long-term EEG monitoring was performed on all patients
preoperatively for localization of the epileptogenic area. As our
cohort only encompasses patients in whom epilepsy surgery was
performed after determination of the surgical area by use of video-
EEG monitoring, the concordance rate of EEG was 100%, both
temporally and extratemporally. Epileptic foci in extratemporal
regions showed 100% concordance with the EEG results, and in all
cases, the lesion was well-localized to a speciﬁc operative area
(sensitivity 1.000). In temporal lobe lesions, the concordance rate
was 100% (sensitivity 1.000), but in ﬁve cases (patients 11, 13, 14,
15, and 18), EEG results were only lateralizing (localization in 78%,
sensitivity 0.783). For these patients, further localization through
employment of imaging modalities was necessary to target the
lesion to a focal resective area (Fig. 1). If EEG and imaging results
proved discordant, as in patients 2, 12, 29, 30, and 31, EEG results
were favored to determine operability.
3.2. MRI
MRI was performed in all patients, and was proven to be useful
and sensitive in localizing epileptogenic lesions in both temporal
and extratemporal areas. In extratemporal lesions, MRI showed a
concordance rate of 84.2% (16/19 patients, sensitivity 0.842), with
localization of the lesion in all concordant cases (84.2%, sensitivity
0.842). Discordance with the epileptic foci was seen in 15.8% of
cases (3/19 patients). In temporal lesions, the concordance rate
was 91.3% (21/23 patients, sensitivity 0.913), with localization of
the lesion achieved in 82.6% (19/23 patients, sensitivity 0.826) and
discordance in 2 cases (8.7%) (Fig. 2).
3.3. FDG-PET
All patients with extratemporal lesion (19 patients) and 22
patients with temporal lobe lesions received FDG-PET studies. In
extratemporal cases, FDG-PET showed concordance with the
epileptic foci in 13 patients (13/19 patients, concordance rate
68.4%, sensitivity 0.684), with precise localization of lesions in 12
cases (12/19 patients, localization rate 63.2%, sensitivity 0.632),
and discordance in six cases (31.6%). In temporal cases, FDG-PET
was able to determine the epileptic foci in 21 patients (21/22
patients; concordance rate, 95.5%; sensitivity, 0.955), with
precise localization in 16 cases (16/22 patients, localization rate
72.7%, sensitivity 0.727), and discordance in one case (4.5%)
(Fig. 3).
Fig. 2. Localization, lateralization, and discordance ratio of epileptic foci for MRI.
Fig. 3. Localization, lateralization, and discordance ratio of epileptic foci for FDG-PET.
Fig. 4. Localization, lateralization, and discordance ratio of epileptic foci for SISCOM.
Table 5
Sensitivity of individual imaging modalities in determining epileptic foci.
EEG Extratemporal Concordance 1.000
Localization 1.000
Temporal Concordance 1.000
Localization 0.783
MRI Extratemporal Concordance 0.842
Localization 0.842
Temporal Concordance 0.913
Localization 0.826
PET Extratemporal Concordance 0.684
Localization 0.632
Temporal Concordance 0.955
Localization 0.727
SISCOM Extratemporal Concordance 0.923
Localization 0.846
Temporal Concordance 1.000
Localization 0.667
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In cases where ictal SPECT was acquired successfully, SISCOM
imageswere constructed tominimize subjectivity,which is prone in
visual analysis of nuclear medical images. SISCOM data were
available in 13 extratemporal and 12 temporal cases. In extra-
temporal cases, SISCOM showed concordance with lesions in 12
cases (12/13 patients, 92.3%, sensitivity 0.923), and discordance in
one case (7.7%),with precise localization in 11 cases (11/13patients,
84.6%, sensitivity 0.846), which was almost equivalent to the
localization power of the MRI images. In temporal lesions, SISCOM
showed concordance in 12 cases (12/12 patients, 100%, sensitivity
1.000) and no cases with discordance (0%), but precise localization
was achieved in eight patients only (8/12 patients, 66.7%, sensitivity
0.667), showing that its sensitivity in temporal area was lower than
in extratemporal areas, and its sensitivity was inferior when
compared to the sensitivity of corresponding PET images (Fig. 4).
3.5. Diagnostic values of MRI, FDG-PET, and SISCOM alone and in
combination
Table 5 lists the sensitivity of each test in detecting epileptogenic
areas, provided as ‘‘concordant’’ or ‘‘localizing’’. Considering thatlocalizing power is more meaningful clinically, higher emphasis
must beplacedon localizing sensitivity than just concordance alone.
It can be seen that MRI has high localization sensitivity in both
extratemporal and temporal lesions, and in temporal lobes, its
Table 6
Statistical analysis of concordance and localization values between temporal and
extratemporal lesions for EEG and imaging modalities in combination.
Modalities in combination p-Value for concordance p-Value for localization
EEG + MRI 0.6640 0.2905
EEG + PET 0.1122 0.6628
EEG + SISCOM 0.4740 0.0366
MRI + PET 0.1435 0.8450
MRI + SISCOM 0.7565 0.2607
PET + SISCOM 0.7565 0.2607
EEG + MRI + PET 0.1435 0.5155
EEG + MRI + SISCOM 0.7565 0.0795
MRI + PET + SISCOM 0.5155 0.2730
EEG + PET + SISCOM 0.7565 0.0795
EEG + PET + MRI + SISCOM 0.5155 0.0776
p-Value of less than 0.05 was considered statistically signiﬁcant for a combined test
to be proven superior in a certain region rather than in another.
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concordance and localization sensitivity in extratemporal regions,
but showed a high concordance rate in temporal areas, and its
localizing sensitivity in temporal areas approaches values observed
withMRI. SISCOMhashighconcordancesensitivity inboth temporal
and extratemporal cases, but although the concordance rate is
highest in temporal areas, the localizing ability is far lower in
comparison, even when compared to other imaging modalities,
while it is highly sensitive in extratemporal regions. Table 6 lists the
p-values for the statistical differences of concordance and localiza-
tion between temporal and extratemporal lesions by EEG and other
imaging modalities in combinations, to verify the diagnostic values
of combinedmodalities in temporal versus extratemporal lesions. It
can be seen that with the sole exception of combined EEG and
SISCOMdata for localization of epileptic lesions, other modalities in
combination failed to prove their usefulness in one speciﬁc region
rather than in another.
3.6. Pathological ﬁndings
Differences in post-operative pathological results were notable
between temporal and extratemporal cohorts. In temporal lobe
patients, the most numerous pathology was hippocampal sclerosis
with normal pathology in temporal cortex (16/23, 69.6%). Other
ﬁndings were microdysgenesis (3/23, 13.0%), dysembryoplastic
neuroepithelial tumor (DNET) (1/23, 4.3%), ganglioglioma (1/23,
4.3%), diffuse astrocytoma (1/23, 4.3%), and cortical dysplasia (1/
23, 4.3%). In extratemporal patients, themost common ﬁndingwas
cortical dysplasia, accounting for 36.8% of the cases (7/19). Other
ﬁndings includedmicrodysgenesis (6/19, 31.6%), ganglioglioma (3/
19, 15.8%), diffuse subpial gliosis (1/19, 5.3%), DNET (1/19, 5.3%),
and a normal pathology in one case (5.3%).
4. Discussion
Recent employment of various nuclear imagingmodalities such
as FDG-PET, SPECT, and SISCOM has made delineation of
epileptogenic zones easier and more accurate. Introduction of
quantitative neuroimaging such as SISCOM and Statistical Para-
metric Mapping (SPM) in particular, have made nuclear image
interpretation more objective. The value of quantitative neuroi-
maging has been shown to be equal to visual interpretation by
trained specialists in adults,8,9 and recent studies by Lee et al. have
hinted at its usefulness in pediatric populations11 as well. A
common belief in pediatric neurology holds that interictal
hypometabolism, which is a requisite for obtaining accurate
FDG-PET data, is lacking in pediatric patients, since interictal
metabolic defect is related to the lifetime duration of seizures.12
The effectiveness of interictal and ictal SPECT, as well asquantitative SISCOM data, still needs to be proven in pediatric
patients, as their efﬁcacy in immature brains has not yet been well
described.
Our study shows that the localizing power of MRI is still highly
accurate if the images are obtainedwith parameters specialized for
detection of subtle cortical anomalies like gradient-echo sequences
and Flair imaging, regardless of the location of the epileptic foci.
FDG-PET and SISCOM were somewhat less universal in their
efﬁcacy, but their concordance with epileptic zones was almost
equal to the concordance observed in adults.13
FDG-PET was highly concordant with epileptic lesions in the
temporal area, which, at 92%, approached the sensitivity of MRI.
Localizing sensitivity was also high at 73%, approaching the
sensitivity seen with MRI and surpassing SISCOM sensitivity in
temporal lobe lesions. In extratemporal lesions, however, FDG-PET
was unreliable as its discordance rate was over 30%, and even
though the lateralization rate was only 5%, compared to a
lateralizing rate of 19% in temporal lobe lesions, its localizing rate
was a mere 63%, which translated to it being the least sensitive
among imaging modalities analyzed.
SISCOM data was useful in detecting pathologic lesions in
extratemporal locations, with a concordance rate of 92.3% and
localization of 84.6%, which is higher than any imaging tools
analyzed. Discordancewas seen in only 7.7% of cases,which showed
that SISCOM analysis is highly sensitive in identifying epileptogenic
lesions with precision. In temporal lesions, SISCOM showed a
concordance rate of 100%, but these results contained a relatively
high portion of lateralizing results in 33.3% of cases and localization
was achieved in a mere 66.7%, which was inferior to PET analysis in
detecting pathologic lesions in this particular region.
Pathological results revealed mostly hippocampal sclerosis
with normal cortical tissue in temporal lesions and cortical
dysplasia or microdysgenesis in extratemporal lesions. This
difference in underlying pathology could be the reason behind
the varying effectiveness of PET and SISCOM in different regions,
but comparative studies on the effectiveness of PET versus SISCOM
in different pathological settings are currently lacking, and further
studies into this ﬁeld are warranted.
When the tests were analyzed in combination to verify their
localizing superiority in one region compared to another, no
statistical differences were found between the various groups
tested, except for EEG and SISCOM in combination, which is
probably indicative of the better analytical ability of these
modalities in detecting lesions in the extratemporal lobe, the best
site in terms of efﬁcacy for SISCOM.
Hence, it could be deduced that ruling out a certain imaging test
by location of the lesion is not practical, but further study employing
larger subsets of samples is required to ascertain this hypothesis.
Singularly, certain imagingmodalities have been shown to bemore
sensitive in certain regions, with MRI being useful in both temporal
and extratemporal lesions. As a tool to supplement electrographical
results, imaging modalities exhibit satisfactorily high concordance
and localizing sensitivity,with lowratesofdiscordance, proving that
they are invaluable assets in supplementing data obtained from
long-term EEG monitoring. FDG-PET was as reliable as MRI in
localizing epileptogenic lesions in temporal lobe cases, even in our
pediatric group with a mean duration of lifetime seizure of 9.67
years. Efﬁcacy of FDG-PET imagingwas lower in extratemporal lobe
lesions. SISCOM, on the other hand, could be counted on to
determine the epileptogenic area in extratemporal lobes with
precision that ismatched only byMRI, while its efﬁcacywas inferior
to othermodalities in temporal areas. Hence, we determined that in
cases of confounding pre-surgical results, MRI, with supplementary
data from PET, would help a physician in establishing correct
diagnosis in temporal lobe epilepsies, while utilization of MRI and
SISCOM data would be wiser in extratemporal cases.
J.T. Kim et al. / Seizure 18 (2009) 504–510510Therewere also profound differences in post-surgical pathology
between the two regions analyzed, and this may be the reason
behind the differing efﬁcacy of each imagingmodalities in different
parts of the brain, but more studies are needed.
Our study was limited in that only three cases of occipital lobe
epilepsy and two cases of parietal lobe epilepsy were included,
making most of the samples either frontal lobe seizures or
temporal lobe seizures. Further studies employing a larger group of
patients would be required to determine the efﬁcacy of each
imaging modality in speciﬁc lobes of the cerebral hemisphere.
There is also the possibility that the localizing power of these
imagingmodalitiesmight bedifferent inpatientswith less favorable
surgical outcomes; namely, patients with Engel class II–IV post-
operative outcomes. However, due to lack of means to locate the
epileptogenic region in this group of patients with precision, direct
comparison of this data with our result is meaningless under this
study’s design, and separate studies exploring the results of imaging
modalities in poorly treated patients are needed.
5. Conclusion
The localizing power of FDG-PET in pediatric patients was
greatest in the temporal lobe, while SISCOM exhibited its greatest
localizing ability in the extratemporal lesions. MRI showed the
greatest versatility and highest accuracy in localizing epilepto-
genic areas in both temporal and extratemporal areas. Various
analytical tools in combination failed to show any statistical
differences at better localizing a pathologic lesion in temporal or
extratemporal regions, except for combinations of EEG and
SISCOM, which were statistically relevant for better differentiation
of lesions in the extratemporal area.
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